• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国政府科技报告 >Efficacy of a Commercial Bacterin in Protecting Strain 13 Guinea Pigs against Bordetella bronchiseptica Pneumonia
【24h】

Efficacy of a Commercial Bacterin in Protecting Strain 13 Guinea Pigs against Bordetella bronchiseptica Pneumonia

机译：商品菌素在保护13株豚鼠对支气管炎博德特氏菌肺炎中的作用

获取原文
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

A commercial Bordetella bronchiseptica bacterin that does not contain adjuvant was evaluated in strain 13/N guinea pigs for efficiency against an airborne challenge of virulent B. bronchiseptica. Vaccinated animals developed humoral antibody titers that ranged from 128 to 1024, as measured by ELISA. When challenged with 325 median lethal doses (LD50) of B. bronchiseptica in a small particle aerosol, the vaccinated guinea pigs were fully protected from lethal effects. Only minimal acute tracheitis with mild multifocal lymphatic hyperplasia occurred in the vaccinated, challenged animals. However, the induced immune response did not completely eliminate the challenge organisms within the 30-day observation period. Sham-vaccinated guinea pigs, on the other hand, died of a fulminant bronchopneumonia within 6 days following aerosol challenge. The commercial bacterin, therefore, provided protection against a massive airborne challenge, and prevented the inducement of significant pathological alterations.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号